Miami, Fla., November 04, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Amazonas Florestal, Ltd. (OTC: AZFL) announced today that the company has provided its shareholders and investors with a recap of the company’s new business developments and disclosed an update on the status of the company’s plans.
AZFL’s Miami, FL affiliate, Green America Laboratories (GAL), submitted construction plans which are currently under review by local county building and planning authorities. The GAL development team is awaiting approval to proceed with the construction and installation of the state-of-the-art laboratory in the coming weeks. The lab setup made by Precision Extraction Solutions has the capacity to produce 225 liters of pure CBD distillate per day and, once operational, will be South Florida’s largest bulk cannabinoid concentrate manufacturer. Business leaders forecast product sales of more than $ 30 million in 2022 for GAL.
AZFL also released its third quarter financial results and disclosures last week showing the highest revenue and gross profit levels of any quarter in the company’s history as a registered issuer. The company reported consolidated operating income of $ 4.885 million and gross profit of more than $ 500,000 for the quarter ended September 30, 2021. Innova Consulting Group, a wholly owned subsidiary of AZFL, which already posts positive financial results, plans to double its income. as it reveals new applications designed for the management of marijuana, as well as applications of agricultural and distribution solutions to an expanding customer base. The new apps are designed for the Latin American cannabis markets. The company is also rapidly growing its customer base among the more than 1,800 cannabis licensees in the country of Colombia who demand the innovative software solutions that Innova provides locally.
AZFL’s partnership with Colombia Dreams Marijuana (CDM) has advanced efforts to complement its labeling designs and mass processing capabilities for products that are registered for sale in Mexico and across Europe from from Italy this winter. CDM holds all licenses for cultivation and production of cannabis derivatives, while also having a long-standing technical and scientific cooperation agreement with the National University of Colombia.
Botanica de la Sierra, AZFL’s Colombian agricultural partner, has agreed to organize Mountain High Apothecary as a subsidiary of AZFL, merging the company’s assets with the aim of exporting the medical marijuana flower grown in Colombia to the European Union and other Latin markets that have legally regulated the activity. . Botanica de la Sierra is also a licensed Colombian producer, manufacturer and distributor of high CBD and medical marijuana products.
The company also held discussions with AZFL’s strategic marketing partner Stilbon Corp. for the introduction of the Colombian high CBD and medical marijuana products custom-made by AZFL in its more than 3,000 locations. sales in the Caribbean, Europe, Asia and South America. Stilbon has been in the consumer product distribution business for over 25 years, specializing in the global wholesale distribution of mid-to-high-end consumer brands and products including branded fragrances, cosmetics, products of health and beauty, wines and spirits and agricultural products. foodstuffs.
Also this week, via Twitter, Amazonas Florestal unveiled the appointment of Alex Otero, one of the directors of Green America Laboratories, as national director for the country of Mexico. Mr. Otero will now head AZFL’s Mexican subsidiary, Magna Leaf México (MLM). Magna Leaf México is in the process of registering custom-made products by AZFL in Colombia for distribution in Mexico, the United States and emerging markets in Latin America.
About Amazonas Florestal Ltd.
Amazonas Florestal, Ltd., headquartered in Miami, Florida, is a natural resource company dedicated to the research and development of innovative projects to transform industrial hemp in legal concentrations of cannabinoids into high CBD products. , without THC and Delta-8. The company also promotes the sustainable management of large tracts of land in the rainforest state of Amazonas, Brazil, and plans to certify and sell registered carbon credits for the preservation of rainforest properties. In 2017, the company changed course to focus on the cultivation, harvesting, research and development of industrial hemp and related products in the United States for domestic and international markets. In 2021, the company is building a major hemp derivative extraction facility in Miami, Florida, dedicated to the production of premium bulk T-Free concentrates. Amazonas Florestal’s goal is to become a leader in the field of cannabinoid extractions, serving laboratories that use these distillates as a raw material for human and animal health / welfare products.
Disclaimer: forward-looking statements
The forward-looking statements contained in this press release regarding Amazonas Florestal Ltd. are made in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increasing levels of competition, new products and technological changes, the Company’s dependence on third party suppliers, intellectual property rights and other risks detailed from time to time in the periodic reports of the company filed with the Securities and Exchange Commission.